Notable Upgrades: PTC Therapeutics, Inc. (PTCT), Nokia Corporation (NOK), Avanir Pharmaceuticals (AVNR)

Investment analysts at Deutsche Bank (DB) initiated coverage on shares of PTC Therapeutics, Inc. (PTCT) in a note issued to investors on Monday. The firm set a ‘Buy’ rating and a $75.00 price target on the stock. DB’s price target would suggest a potential upside of 129.21% from the stock’s previous close. PTC Therapeutics, Inc. […] View the full post at: Notable Upgrades: PTC Therapeutics, Inc. (PTCT), Nokia Corporation (NOK), Avanir Pharmaceuticals (AVNR) Related posts: Pre-Market Earnings (May 3) Caterpillar Inc. Downgraded to “Neutral” at BofA